Physician beliefs and practices for adjuvant and salvage radiation therapy after prostatectomy

Timothy N. Showalter, Nitin Ohri, Kristopher G. Teti, Kathleen A. Foley, Scott W. Keith, Edouard J. Trabulsi, Costas D. Lallas, Adam P. Dicker, Jean Hoffman-Censits, Laura T. Pizzi, Leonard G. Gomella

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

Purpose: Despite results of randomized trials that support adjuvant radiation therapy (RT) after radical prostatectomy (RP) for prostate cancer with adverse pathologic features (APF), many clinicians favor selective use of salvage RT. This survey was conducted to evaluate the beliefs and practices of radiation oncologists (RO) and urologists (U) regarding RT after RP. Methods and Materials: We designed a Web-based survey of post-RP RT beliefs and policies. Survey invitations were e-mailed to a list of 926 RO and 591 U. APF were defined as extracapsular extension, seminal vesicle invasion, or positive surgical margin. Differences between U and RO in adjuvant RT recommendations were evaluated by comparative statistics. Multivariate analyses were performed to evaluate factors predictive of adjuvant RT recommendation. Results: Analyzable surveys were completed by 218 RO and 92 U (overallresponse rate, 20%). Adjuvant RT was recommended based on APF by 68% of respondents (78% RO, 44% U, p <0.001). U were less likely than RO to agree that adjuvant RT improves survival and/or biochemical control (p < 0.0001). PSA thresholds for salvage RT were higher among U than RO (p < 0.001). Predicted rates of erectile dysfunction due to RT were higher among U than RO (p <0.001). On multivariate analysis, respondent specialty was the only predictor of adjuvant RT recommendations. Conclusions: U are less likely than RO to recommend adjuvant RT. Future research efforts should focus on defining the toxicities of post-RP RT and on identifying the subgroups of patients who will benefit from adjuvant vs. selective salvage RT.

Original languageEnglish (US)
JournalInternational Journal of Radiation Oncology Biology Physics
Volume82
Issue number2
DOIs
StatePublished - Feb 1 2012
Externally publishedYes

Fingerprint

Salvage Therapy
physicians
Prostatectomy
radiation therapy
Radiotherapy
Physicians
radiation
recommendations
Multivariate Analysis
Radiation Oncologists
Seminal Vesicles
Erectile Dysfunction
subgroups
toxicity
lists

Keywords

  • Adjuvant radiation therapy
  • Prostate cancer
  • Prostatectomy
  • Radiation oncologist
  • Urologist

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Radiation
  • Cancer Research

Cite this

Physician beliefs and practices for adjuvant and salvage radiation therapy after prostatectomy. / Showalter, Timothy N.; Ohri, Nitin; Teti, Kristopher G.; Foley, Kathleen A.; Keith, Scott W.; Trabulsi, Edouard J.; Lallas, Costas D.; Dicker, Adam P.; Hoffman-Censits, Jean; Pizzi, Laura T.; Gomella, Leonard G.

In: International Journal of Radiation Oncology Biology Physics, Vol. 82, No. 2, 01.02.2012.

Research output: Contribution to journalArticle

Showalter, TN, Ohri, N, Teti, KG, Foley, KA, Keith, SW, Trabulsi, EJ, Lallas, CD, Dicker, AP, Hoffman-Censits, J, Pizzi, LT & Gomella, LG 2012, 'Physician beliefs and practices for adjuvant and salvage radiation therapy after prostatectomy', International Journal of Radiation Oncology Biology Physics, vol. 82, no. 2. https://doi.org/10.1016/j.ijrobp.2011.04.003
Showalter, Timothy N. ; Ohri, Nitin ; Teti, Kristopher G. ; Foley, Kathleen A. ; Keith, Scott W. ; Trabulsi, Edouard J. ; Lallas, Costas D. ; Dicker, Adam P. ; Hoffman-Censits, Jean ; Pizzi, Laura T. ; Gomella, Leonard G. / Physician beliefs and practices for adjuvant and salvage radiation therapy after prostatectomy. In: International Journal of Radiation Oncology Biology Physics. 2012 ; Vol. 82, No. 2.
@article{bdbc658ef70848fc9b98e7335a994b4b,
title = "Physician beliefs and practices for adjuvant and salvage radiation therapy after prostatectomy",
abstract = "Purpose: Despite results of randomized trials that support adjuvant radiation therapy (RT) after radical prostatectomy (RP) for prostate cancer with adverse pathologic features (APF), many clinicians favor selective use of salvage RT. This survey was conducted to evaluate the beliefs and practices of radiation oncologists (RO) and urologists (U) regarding RT after RP. Methods and Materials: We designed a Web-based survey of post-RP RT beliefs and policies. Survey invitations were e-mailed to a list of 926 RO and 591 U. APF were defined as extracapsular extension, seminal vesicle invasion, or positive surgical margin. Differences between U and RO in adjuvant RT recommendations were evaluated by comparative statistics. Multivariate analyses were performed to evaluate factors predictive of adjuvant RT recommendation. Results: Analyzable surveys were completed by 218 RO and 92 U (overallresponse rate, 20{\%}). Adjuvant RT was recommended based on APF by 68{\%} of respondents (78{\%} RO, 44{\%} U, p <0.001). U were less likely than RO to agree that adjuvant RT improves survival and/or biochemical control (p < 0.0001). PSA thresholds for salvage RT were higher among U than RO (p < 0.001). Predicted rates of erectile dysfunction due to RT were higher among U than RO (p <0.001). On multivariate analysis, respondent specialty was the only predictor of adjuvant RT recommendations. Conclusions: U are less likely than RO to recommend adjuvant RT. Future research efforts should focus on defining the toxicities of post-RP RT and on identifying the subgroups of patients who will benefit from adjuvant vs. selective salvage RT.",
keywords = "Adjuvant radiation therapy, Prostate cancer, Prostatectomy, Radiation oncologist, Urologist",
author = "Showalter, {Timothy N.} and Nitin Ohri and Teti, {Kristopher G.} and Foley, {Kathleen A.} and Keith, {Scott W.} and Trabulsi, {Edouard J.} and Lallas, {Costas D.} and Dicker, {Adam P.} and Jean Hoffman-Censits and Pizzi, {Laura T.} and Gomella, {Leonard G.}",
year = "2012",
month = "2",
day = "1",
doi = "10.1016/j.ijrobp.2011.04.003",
language = "English (US)",
volume = "82",
journal = "International Journal of Radiation Oncology Biology Physics",
issn = "0360-3016",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Physician beliefs and practices for adjuvant and salvage radiation therapy after prostatectomy

AU - Showalter, Timothy N.

AU - Ohri, Nitin

AU - Teti, Kristopher G.

AU - Foley, Kathleen A.

AU - Keith, Scott W.

AU - Trabulsi, Edouard J.

AU - Lallas, Costas D.

AU - Dicker, Adam P.

AU - Hoffman-Censits, Jean

AU - Pizzi, Laura T.

AU - Gomella, Leonard G.

PY - 2012/2/1

Y1 - 2012/2/1

N2 - Purpose: Despite results of randomized trials that support adjuvant radiation therapy (RT) after radical prostatectomy (RP) for prostate cancer with adverse pathologic features (APF), many clinicians favor selective use of salvage RT. This survey was conducted to evaluate the beliefs and practices of radiation oncologists (RO) and urologists (U) regarding RT after RP. Methods and Materials: We designed a Web-based survey of post-RP RT beliefs and policies. Survey invitations were e-mailed to a list of 926 RO and 591 U. APF were defined as extracapsular extension, seminal vesicle invasion, or positive surgical margin. Differences between U and RO in adjuvant RT recommendations were evaluated by comparative statistics. Multivariate analyses were performed to evaluate factors predictive of adjuvant RT recommendation. Results: Analyzable surveys were completed by 218 RO and 92 U (overallresponse rate, 20%). Adjuvant RT was recommended based on APF by 68% of respondents (78% RO, 44% U, p <0.001). U were less likely than RO to agree that adjuvant RT improves survival and/or biochemical control (p < 0.0001). PSA thresholds for salvage RT were higher among U than RO (p < 0.001). Predicted rates of erectile dysfunction due to RT were higher among U than RO (p <0.001). On multivariate analysis, respondent specialty was the only predictor of adjuvant RT recommendations. Conclusions: U are less likely than RO to recommend adjuvant RT. Future research efforts should focus on defining the toxicities of post-RP RT and on identifying the subgroups of patients who will benefit from adjuvant vs. selective salvage RT.

AB - Purpose: Despite results of randomized trials that support adjuvant radiation therapy (RT) after radical prostatectomy (RP) for prostate cancer with adverse pathologic features (APF), many clinicians favor selective use of salvage RT. This survey was conducted to evaluate the beliefs and practices of radiation oncologists (RO) and urologists (U) regarding RT after RP. Methods and Materials: We designed a Web-based survey of post-RP RT beliefs and policies. Survey invitations were e-mailed to a list of 926 RO and 591 U. APF were defined as extracapsular extension, seminal vesicle invasion, or positive surgical margin. Differences between U and RO in adjuvant RT recommendations were evaluated by comparative statistics. Multivariate analyses were performed to evaluate factors predictive of adjuvant RT recommendation. Results: Analyzable surveys were completed by 218 RO and 92 U (overallresponse rate, 20%). Adjuvant RT was recommended based on APF by 68% of respondents (78% RO, 44% U, p <0.001). U were less likely than RO to agree that adjuvant RT improves survival and/or biochemical control (p < 0.0001). PSA thresholds for salvage RT were higher among U than RO (p < 0.001). Predicted rates of erectile dysfunction due to RT were higher among U than RO (p <0.001). On multivariate analysis, respondent specialty was the only predictor of adjuvant RT recommendations. Conclusions: U are less likely than RO to recommend adjuvant RT. Future research efforts should focus on defining the toxicities of post-RP RT and on identifying the subgroups of patients who will benefit from adjuvant vs. selective salvage RT.

KW - Adjuvant radiation therapy

KW - Prostate cancer

KW - Prostatectomy

KW - Radiation oncologist

KW - Urologist

UR - http://www.scopus.com/inward/record.url?scp=82455180651&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=82455180651&partnerID=8YFLogxK

U2 - 10.1016/j.ijrobp.2011.04.003

DO - 10.1016/j.ijrobp.2011.04.003

M3 - Article

C2 - 21605945

AN - SCOPUS:82455180651

VL - 82

JO - International Journal of Radiation Oncology Biology Physics

JF - International Journal of Radiation Oncology Biology Physics

SN - 0360-3016

IS - 2

ER -